Replies to post #368448 on Anavex Life Sciences Corp (AVXL)

[Steady_T]

Many biotechs don't have a paradigm changing drug in multiple trials simultaneously.

At present the company doesn't need much additional capital if any.

We shall see if Missling agrees with you on hedging his bets.